This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Synovus (SNV) Rewards Investors With 11.8% Dividend Hike
by Zacks Equity Research
Synovus (SNV) announces a sequential hike of 11.8% in its quarterly cash dividend. This, along with share repurchases and capital strength, will continue to enhance shareholders' value.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Synovus (SNV) Q4 Earnings Miss Estimates as Provisions Rise
by Zacks Equity Research
Higher provisions and non-interest expenses and a fall in fee income hurt Synovus' (SNV) Q4 earnings, while loan growth and rising rates support NII.
Wall Street Analysts See a 25.55% Upside in Synovus (SNV): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Synovus (SNV) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Synovus Financial (SNV) Q4 Earnings Lag Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of -1.46% and 0.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Independent Bank Group (IBTX) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Independent Bank Group (IBTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus Financial (SNV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Loan Growth, Rising Rates Aid Synovus (SNV) Despite High Costs
by Zacks Equity Research
Synovus' (SNV) top line should continue to benefit from higher rates, along with rising loans and deposits. Yet, continued investments in technology keep its bottom line under pressure.
Synovus (SNV) Stock Down Despite Q3 Earnings Beat, Higher NII
by Zacks Equity Research
Rising net interest income, net interest margin and total loans aid Synovus Financial's (SNV) Q3 results. However, rising non-interest expenses and falling fee income and deposits were headwinds.
Synovus Financial (SNV) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of 4.69% and 2.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Home Bancorp (HBCP) Q3 Earnings Lag Estimates
by Zacks Equity Research
Home Bancorp (HBCP) delivered earnings and revenue surprises of -3.03% and 1.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cadence (CADE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cadence (CADE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus Financial (SNV) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Synovus (SNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Barclays (BCS) Q2 Earnings Decline Y/Y, Revenues & Costs Rise
by Zacks Equity Research
Barclays (BCS) records a rise in revenues and expenses in the second quarter of 2022.
Deutsche Bank (DB) Q2 Net Income Improves Y/Y, Cost Down
by Zacks Equity Research
Deutsche Bank's (DB) second-quarter revenues increase year over year on higher revenues from all segments except Corporate & Other.
Navient (NAVI) Up as Q2 Earnings Beat Estimates on Lower Costs
by Zacks Equity Research
Decline in expenses supports Navient's (NAVI) Q2 earnings. However, a fall in NII and fee income weighs on it.
Will Synovus (SNV) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Synovus (SNV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Believe Synovus (SNV) Could Rally 27%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Synovus (SNV) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Synovus' (SNV) Stock Up on Q2 Earnings Beat, Higher NII
by Zacks Equity Research
Synovus Financial's (SNV) second-quarter revenues increase year over year. However, a rise in expenses and a fall in fee income hurt.
Synovus Financial (SNV) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of 6.36% and 0.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why American Express (AXP) Might Beat on Q2 Earnings
by Zacks Equity Research
Second-quarter results of American Express (AXP) are likely to reflect a rise in the overall spending level.
Republic Bancorp (RBCAA) to Report Q2 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Republic Bancorp (RBCAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synovus Financial (SNV) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Synovus (SNV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Professional Holding (PFHD) Stock Jumps 5.7%: Will It Continue to Soar?
by Zacks Equity Research
Professional Holding (PFHD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Balance-Sheet Strength Aids Synovus (SNV) Despite High Costs
by Zacks Equity Research
Synovus' (SNV) top line should continue to benefit from rising loans and deposits. Yet, continued investments in technology keep the bottom line under pressure.